Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed on the page, replacing the previous v3.6.2. This reflects a minor update to the page’s revision tag without changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-04T03:47:57.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page used for maintenance. This update does not modify visible content.
    Difference
    0.1%
    Check dated 2026-06-27T01:25:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page loses several regulatory and documentation labels, including FDA-regulated status and IPD-related terms, along with associated descriptors, which changes how regulatory context and study documents are surfaced.
    Difference
    19%
    Check dated 2026-06-19T22:42:06.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New helper sections were added to the study page (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment header was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the page footer revision label updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T14:32:36.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor deployment update.
    Difference
    0.1%
    Check dated 2026-06-05T10:07:36.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing v3.5.3, indicating a small version update to the ClinicalTrials.gov page rendering.
    Difference
    0.1%
    Check dated 2026-05-15T04:57:26.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.